Effect of metabolic inhibitors on the ability of tumor cells to express antigen and bind complement components C4 and C3
- PMID: 52405
Item in Clipboard
Effect of metabolic inhibitors on the ability of tumor cells to express antigen and bind complement components C4 and C3
Cancer Res.
1975 Nov.
Abstract
Metabolic inhibitors commonly used in the treatment of cancer increase the ability of antibody and complement to kill guinea pig tumor cells in vitro. No correlation was found between increased killing and changes in cell surface antigen concentration or binding of complement components C4 and C3.
Similar articles
-
Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement.Cancer Res. 1975 Nov;35(11 Pt 1):3195-203. Cancer Res. 1975. PMID: 52404
-
Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.Cancer Res. 1977 May;37(5):1432-7. Cancer Res. 1977. PMID: 192450
-
Lysis of tumor cells by antibody and complement. III. Lack of correlation between antigen movement and cell lysis.J Immunol. 1975 Aug;115(2):473-5. J Immunol. 1975. PMID: 50364
-
Tumour-associated antigens and tumour-host interactions.Proc R Soc Med. 1971 Oct;64(10):1039-42. doi: 10.1177/003591577106401013. Proc R Soc Med. 1971. PMID: 4335921 Free PMC article. Review. No abstract available.
-
Complement metabolism: cellular and humoral regulation.Transplant Rev. 1976;32:3-11. doi: 10.1111/j.1600-065x.1976.tb00225.x. Transplant Rev. 1976. PMID: 790688 Review. No abstract available.
Cited by
-
Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivation.Proc Natl Acad Sci U S A. 1986 Dec;83(23):9144-8. doi: 10.1073/pnas.83.23.9144. Proc Natl Acad Sci U S A. 1986. PMID: 3466179 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous